MARC보기
LDR01465casuu2200337 a 4500
001000000524099
00520030509135400
008030509s2002 mdu m 0 a0eng d
020 ▼a 1889788139
022 ▼a 01957996
040 ▼a 225009 ▼d 225009
08204 ▼a 615.1373 ▼2 20
090 ▼a 615.1373 ▼b U58u26 ▼c v.1-2
2220 ▼a The United States pharmacopeia. The national formulary
24504 ▼a The United States pharmacopeia. The national formulary: ▼b 2003/ ▼c by authority of the United States Pharmacopeial Convention.
24630 ▼a The National formulary.
24610 ▼a US pharmacopeia.
24614 ▼a USP, NF.
24618 ▼a U.S. pharmacopeia, national formulary.
260 ▼a Rockville, Maryland: ▼b United States Pharmacopeial Convention, ▼c 2002.
300 ▼a 2 v.(xxxvi, 2921 p.): ▼b ill.; ▼c 30 cm.
3620 ▼a USP 26th revision = NF 21th ed.
500 ▼a Prepared by the Committee of Revision.
580 ▼a Formed by the union of: The Pharmacopeia of the United States of America (The United States pharmacopeia), and: The National formulary.
6502 ▼a Formularies ▼z United States ▼v Periodicals.
6502 ▼a Pharmacopoeias ▼z United States ▼v Periodicals.
7102 ▼a United States Pharmacopeial Convention. ▼b Committee of Revision.
73002 ▼a National formulary.
78014 ▼t The Pharmacopeia of the United States of America (The United States pharmacopeia)
936 ▼a July 1, 2003
990 ▼a 손기순 ▼b 박춘규